References

1. Maheu, E.; Cadet, C.; Marty, M.; Moyse, D.; Kerloch, I.; Coste, P.; Dougados, M.; Mazieres, B.; Spector, T.D.; Halhol, H.; et al. Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: The ERADIAS study. Ann. Rheum. Dis. 2014, 73, 376–384.
2. Pavelka, K.; Coste, P.; Geher, P.; Krejci, G. Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee. Clin. Rheumatol. 2010, 29, 659–670.
3. Cameron, M.; Chrubasik, S. Oral herbal therapies for treating osteoarthritis. Cochrane Database Syst. Rev. 2014, 22.
4. Andriamanalijaona, R.; Benateau, H.; Barre, P.E.; Boumediene, K.; Labbe, D.; Compere, J.F.; Pujol, J.P. Effect of interleukin-1b on transforming growth factor-beta and bone morphogenetic protein-2 expression in human periodontal ligament and alveolar bone cells in culture: Modulation by avocado and soybean unsaponifiables. J. Periodontol. 2006, 77, 1156–1166.
5. Au, R.Y.; Al-Talib, T.K.; Au, A.Y.; Phan, P.V.; Frondoza, C.G. Avocado soybean unsaponifiables (ASU) suppress TNF-α, IL-1β, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthr. Cartil. 2007, 15, 1249–1255.
6. Eser, O.; Songur, A.; Yaman, M.; Cosar, M.; Fidan, H.S.; Sahin, O.; Mollaoglu, H.; Buyukbas, S. The protective effect of avocado soybean unsaponifilables on brain ischemia/reperfusion injury in rat prefrontal cortex. Br. J. Neurosurg. 2011, 25, 701–706.
7. Ghasemian, M.; Owlia, S.; Owlia, M.B. Review of anti-inflammatory herbal medicines. Adv. Pharmacol. Sci. 2016, 2016.
8. Christiansen, B.A.; Bhatti, S.; Goudarzi, R.; Emami, S. Management of osteoarthritis with avocado/soybean unsaponifiables. Cartilage 2015, 6, 30–44.
9. Ernst, E. Avocado–soybean unsaponifiables (ASU) for osteoarthritis–a systematic review. Clin. Rheumatol. 2003, 22, 285–288.
10. Hashemibeni, B.; Valiani, A.; Esmaeli, M.; Kazemi, M.; Aliakbari, M.; Iranpour, F.G. Comparison of the efficacy of piascledine and transforming growth factor β1 on chondrogenic differentiation of human adipose-derived stem cells in fibrin and fibrin-alginate scaffolds. Iran. J. Basic Med Sci. 2018, 21, 212.
11. Cho, S.-J.; Oh, S.-H.; Pridmore, R.D.; Juillerat, M.A.; Lee, C.-H. Purification and characterization of proteases from Bacillus amyloliquefaciens isolated from traditional soybean fermentation starter. J. Agric. Food Chem. 2003, 51, 7664–7670.
12. Taylor, J.F.; Goudarzi, R.; Yazdi, P.G.; Pedersen, B.A. In vitro effects of arthrocen, an avocado/soy unsaponifiables agent, on inflammation and global gene expression in human monocytes. Int. J. Chem. 2017, 9, 31.
13. Henrotin, Y. Avocado/Soybean Unsaponifiables (Piacledine® 300) show beneficial effect on the metabolism of osteoarthritic cartilage, synovium and subchondral bone: An overview of the mechanisms. Aims Med Sci. 2018, 5, 33–52.
14. Prieto Vidal, N.; Adeseun Adigun, O.; Pham, T.; Mumtaz, A.; Manful, C.; Callahan, G.; Stewart, P.; Keough, D.; Thomas, R. The Effects of Cold Saponification on the Unsaponified Fatty Acid Composition and Sensory Perception of Commercial Natural Herbal Soaps. Molecules 2018, 23, 2356.
15. Uquiche, E.; Romero, V.; Ortiz, J.; Del Valle, J. Extraction of oil and minor lipids from cold-press rapeseed cake with supercritical CO2. Braz. J. Chem. Eng. 2012, 29, 585–598.
16. EG, B. A rapid method of total lipid extraction and purification. Canj. Biochem. Physiol. 1959, 37, 911–917.
17. Folch, J.; Lees, M.; Stanley, G.S. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509.
18. Hara, A.; Radin, N.S. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 1978, 90, 420–426.
19. Dewick, P.M.; Fattorusso, E. Chimica, biosintesi e bioattività delle sostanze naturali; Piccin: Padova, Italy, 2012.
20. Traber, M.G.; Atkinson, J. Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 2007, 43, 4–15.
21. Sozen, E.; Demirel, T.; Ozer, N.K. Vitamin E: Regulatory role in the cardiovascular system. Iubmb Life 2019, 71, 507–515.
22. Lee, G.; Han, S. The role of vitamin E in immunity. Nutrients 2018, 10, 1614.
23. Chin, K.Y.; Ima-Nirwana, S. The role of vitamin E in preventing and treating osteoarthritis-a review of the current evidence. Front. Pharmacol. 2018, 9, 946.
24. Peh, H.Y.; Tan, W.D.; Liao, W.; Wong, W.F. Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol. Pharmacol. Ther. 2016, 162, 152–169.
25. Sen, C.K.; Khanna, S.; Roy, S.; Packer, L. Molecular Basis of Vitamin E Action Tocotrienol potently inhibits glutamate-induced pp60c-Src Kinase activation and death of ht4 neuronal cells. J. Biol. Chem. 2000, 275, 13049–13055.
26. Pearce, B.C.; Parker, R.A.; Deason, M.E.; Qureshi, A.A.; Wright, J.K. Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 1992, 35, 3595–3606.
27. Serbinova, E.; Kagan, V.; Han, D.; Packer, L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 1991, 10, 263–275.
28. Bagchi, D.; Preuss, H.G. Phytopharmaceuticals in Cancer Chemoprevention; CRC Press: Boca Raton, FL, USA, 2004.
29. Jones, P.J.; MacDougall, D.E.; Ntanios, F.; Vanstone, C.A. Dietary phytosterols as cholesterol-lowering agents in humans. Can. J. Physiol. Pharmacol. 1997, 75, 217–227.
30. Moreau, R.A.; Whitaker, B.D.; Hicks, K.B. Phytosterols, phytostanols, and their conjugates in foods: Structural diversity, quantitative analysis, and health-promoting uses. Prog Lipid Res. 2002, 41, 457–500.
31. Xu, F.; Rychnovsky, S.D.; Belani, J.D.; Hobbs, H.H.; Cohen, J.C.; Rawson, R.B. Dual roles for cholesterol in mammalian cells. Proc. Natl. Acad. Sci. USA 2005, 102, 14551–14556.
32. Kritchevsky, D.; Chen, S.C. Phytosterols—health benefits and potential concerns: A review. Nutr. Res. 2005, 25, 413–428.
33. Plat, J.; Baumgartner, S.; Vanmierlo, T.; Lütjohann, D.; Calkins, K.; Burrin, D.; Guthrie, G.; Thijs, C.; Te Velde, A.; Vreugdenhil, A. Plant-based sterols and stanols in health & disease:“Consequences of human development in a plant-based environment?”. Prog. Lipid Res. 2019.
34. Pohndorf, R.; Cadaval Jr, T.; Pinto, L. Kinetics and thermodynamics adsorption of carotenoids and chlorophylls in rice bran oil bleaching. J. Food Eng. 2016, 185, 9–16.
35. Johnson, E.J. The role of carotenoids in human health. Nutr. Clin. Care 2002, 5, 56–65.
36. Eggersdorfer, M.; Wyss, A. Carotenoids in human nutrition and health. Arch. Biochem. Biophys. 2018, 652, 18–26.
37. Khoo, H.-E.; Prasad, K.N.; Kong, K.-W.; Jiang, Y.; Ismail, A. Carotenoids and their isomers: Color pigments in fruits and vegetables. Molecules 2011, 16, 1710–1738.
38. Stahl, W.; Sies, H. β-Carotene and other carotenoids in protection from sunlight. Am. J. Clin. Nutr. 2012, 96, 1179S–1184S.
39. Gandul-Rojas, B.; Roca, M.; Gallardo-Guerrero, L. Chlorophylls and carotenoids in food products from olive tree. In Products Olive Tree, 1st ed.; Intech: London, UK, 2016; pp. 67–98.
40. Canniffe, D.P.; Thweatt, J.L.; Chew, A.G.M.; Hunter, C.N.; Bryant, D.A. A paralog of a bacteriochlorophyll biosynthesis enzyme catalyzes the formation of 1, 2-dihydrocarotenoids in green sulfur bacteria. J. Biol. Chem. 2018, 293, 15233–15242.
41. Hoober, J.K.; Eggink, L.L.; Chen, M. Chlorophylls, ligands and assembly of light-harvesting complexes in chloroplasts. Photosynth. Res. 2007, 94, 387–400.
42. Bowers, W.F. Chlorophyll in wound healing and suppurative disease. Am. J. Surg. 1947, 73, 37–50.
43. Edwards, B. Treatment of chronic leg ulcers with ointment containing soluble chlorophyll. Physiotherapy 1954, 40, 177–179.
44. Mishra, V.K.; Bacheti, R.; Husen, A. Medicinal uses of chlorophyll: A critical overview. Chlorophyll Struct. Funct. Med. Uses. Hauppauge Nova Sci. Publ. 2012, 177–196.
45. Egner, P.A.; Stansbury, K.H.; Snyder, E.P.; Rogers, M.E.; Hintz, P.A.; Kensler, T.W. Identification and characterization of chlorin e4 ethyl ester in sera of individuals participating in the chlorophyllin chemoprevention trial. Chem. Res. Toxicol. 2000, 13, 900–906.
46. Ferruzzi, M.G.; Blakeslee, J. Digestion, absorption, and cancer preventative activity of dietary chlorophyll derivatives. Nutr. Res. 2007, 27, 1–12.
47. Werman, M.; Neeman, I.; Mokady, S. Avocado oils and hepatic lipid metabolism in growing rats. Food Chem. Toxicol. 1991, 29, 93–99.
48. Gutfinger, T.; Letan, A. Studies of unsaponifiables in several vegetable oils. Lipids 1974, 9, 658–663.
49. Normén, L.; Dutta, P.; Lia, Å.; Andersson, H. Soy sterol esters and β-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am. J. Clin. Nutr. 2000, 71, 908–913.
50. Veronezi, C.M.; Jorge, N. Effect of Carica papaya and Cucumis melo seed oils on the soybean oil stability. Food Sci. Biotechnol. 2018, 27, 1031–1040.
51. Manaf, Y.N.; Rahardjo, A.P.; Yusof, Y.A.; Desa, M.N.; Nusantoro, B.P. Lipid characteristics and tocopherol content of the oils of native avocado cultivars grown in Indonesia. Int. J. Food Prop. 2018, 21, 2758–2771.
52. Pokkanta, P.; Sookwong, P.; Tanang, M.; Setchaiyan, S.; Boontakham, P.; Mahatheeranont, S. Simultaneous determination of tocols, γ-oryzanols, phytosterols, squalene, cholecalciferol and phylloquinone in rice bran and vegetable oil samples. Food Chem. 2019, 271, 630–638.
53. Li, X.-K.; Ji, W.-J.; Zhao, J.; Wang, S.-J.; Au, C.-T. Ammonia decomposition over Ru and Ni catalysts supported on fumed SiO2, MCM-41, and SBA-15. J. Catal. 2005, 236, 181–189.
54. Jorge, T.d.S.; Polachini, T.C.; Dias, L.S.; Jorge, N.; Telis-Romero, J. Physicochemical and rheological characterization of avocado oils. Ciência E Agrotecnologia 2015, 39, 390–400.
55. Patel, N.K. Phytotherapeutic Investigation of Major Herbal Steroids to Explore their Potential as an Alternative to Synthetic Steroids. Ph.D. Thesis, Saurashtra University, Rajkot, Gujarat, India, 2011.
56. Sankowski, A.J.; Łebkowska, U.M.; Ćwikła, J.; Walecka, I.; Walecki, J. Psoriatic arthritis. Pol. J. Radiol. 2013, 78, 7.
57. Rogoveanu, O.C.; Calina, D.; Cucu, M.G.; Burada, F.; Docea, A.O.; Sosoi, S.; Stefan, E.; Ioana, M.; Burada, E. Association of cytokine gene polymorphisms with osteoarthritis susceptibility. Exp. Ther. Med. 2018, 16, 2659–2664.
58. Oliveira, G.; Paula, L.; Souza, J.; Spin-Neto, R.; Stavropoulos, A.; Marcantonio, R. Effect of avocado/soybean unsaponifiables on ligature-induced bone loss and bone repair after ligature removal in rats. J. Periodontal. Res. 2016, 51, 332–341.
59. Martel-Pelletier, J.; Boileau, C.; Pelletier, J.-P.; Roughley, P.J. Cartilage in normal and osteoarthritis conditions. Best Pract. Res. Clin. Rheumatol. 2008, 22, 351–384.
60. Maldonado, M.; Nam, J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res. Int. 2013, 2013.
61. Duan, L.; Ma, B.; Liang, Y.; Chen, J.; Zhu, W.; Li, M.; Wang, D. Cytokine networking of chondrocyte dedifferentiation in vitro and its implications for cell-based cartilage therapy. Am. J. Transl. Res. 2015, 7, 194.
62. Wojdasiewicz, P.; Poniatowski, L.; Szukiewicz, D. The role of inflammatory and antiinflammatory cytokines in the pathogenesis of osteoarthritis: Review article. Mediat. Inflammation. Usa Hindawi Publ. Corp. 2014, 1–20.
63. Lee, A.S.; Ellman, M.B.; Yan, D.; Kroin, J.S.; Cole, B.J.; van Wijnen, A.J.; Im, H.-J. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013, 527, 440–447.
64. Scanzello, C.R. Chemokines and inflammation in osteoarthritis: Insights from patients and animal models. J. Orthop. Res. 2017, 35, 735–739.
65. Goldring, M.B.; Berenbaum, F. The regulation of chondrocyte function by proinflammatory mediators: Prostaglandins and nitric oxide. Clin. Orthop. Relat. Res. 2004, 427, S37–S46.
66. Abramson, S.B. Inflammation in osteoarthritis. J. Rheumatol. Suppl. 2004, 70, 70–76.
67. Henrotin, Y.; Labasse, A.; Jaspar, J.; De Groote, D.; Zheng, S.; Guillou, G.; Reginster, J. Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E 2 production by human articular chondrocytes. Clin. Rheumatol. 1998, 17, 31–39.
68. Henrotin, Y.E.; Sanchez, C.; Deberg, M.A.; Piccardi, N.; Guillou, G.B.; Msika, P.; Reginster, J.-Y.L. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J. Rheumatol. 2003, 30, 1825–1834.
69. Ameye, L.G.; Chee, W.S. Osteoarthritis and nutrition. From nutraceuticals to functional foods: A systematic review of the scientific evidence. Arthritis Res. Ther. 2006, 8, R127.
70. Long, L.; Soeken, K.; Ernst, E. Herbal medicines for the treatment of osteoarthritis: A systematic review. Rheumatology 2001, 40, 779–793.
71. Blotman, F.; Maheu, E.; Wulwik, A.; Caspard, H.; Lopez, A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev. Du Rhum. (Engl. Ed.) 1997, 64, 825–834.
72. Morton, A.J.; Campbell, N.B.; J’mai, M.G.; Redding, W.R.; Blikslager, A.T. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Res. Vet. Sci. 2005, 78, 189–192.
73. Beluche, L.A.; Bertone, A.L.; Anderson, D.E.; Rohde, C. Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism. Am. J. Vet. Res. 2001, 62, 1916–1921.
74. Goudarzi, R.; Reid, A.; McDougall, J.J. Evaluation of the novel avocado/soybean unsaponifiable Arthrocen to alter joint pain and inflammation in a rat model of osteoarthritis. PLos ONE 2018, 13, e0191906.
75. Gabay, O.; Gosset, M.; Levy, A.; Salvat, C.; Sanchez, C.; Pigenet, A.; Sautet, A.; Jacques, C.; Berenbaum, F. Stress-induced signaling pathways in hyalin chondrocytes: Inhibition by Avocado–Soybean Unsaponifiables (ASU). Osteoarthr. Cartil. 2008, 16, 373–384.
76. He, F.-J.; Chen, J.-Q. Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms. Food Sci. Hum. Wellness 2013, 2, 146–161.
77. Miller, M. Dyslipidemia and cardiovascular risk: The importance of early prevention. Qjm Int. J. Med. 2009, 102, 657–667.
78. Service, U.A.R. USDA National Nutrient Database for Standard Reference; USDA: Washington, DC, USA, 2004.
79. Ownby, S.L.; Fortuno, L.V.; Au, A.Y.; Grzanna, M.W.; Rashmir-Raven, A.M.; Frondoza, C.G. Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination. J. Inflamm. 2014, 11, 8.
80. Altinel, L.; Saritas, Z.K.; Kose, K.C.; Pamuk, K.; Aksoy, Y.; Serteser, M. Treatment with unsaponifiable extracts of avocado and soybean increases TGF-β1 and TGF-β2 levels in canine joint fluid. Tohoku J. Exp. Med. 2007, 211, 181–186.
81. Kut-Lasserre, C.; Miller, C.C.; Ejeil, A.; Gogly, B.; Dridi, M.; Piccardi, N.; Guillou, B.; Pellat, B.; Godeau, G. Effect of avocado and soybean unsaponifiables on gelatinase A (MMP-2), stromelysin 1 (MMP-3), and tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2) secretion by human fibroblasts in culture. J. Periodontol. 2001, 72, 1685–1694.
82. Cinelli, M.; Guiducci, S.; Del Rosso, A.; Pignone, A.; Del Rosso, M.; Fibbi, G.; Serratì, S.; Gabrielli, A.; Giacomelli, R.; Piccardi, N. Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. Scand. J. Rheumatol. 2006, 35, 346–350.
83. Grzanna, M.W.; Ownby, S.L.; Heinecke, L.F.; Au, A.Y.; Frondoza, C.G. Inhibition of cytokine expression and prostaglandin E2 production in monocyte/macrophage-like cells by avocado/soybean unsaponifiables and chondroitin sulfate. J. Complementary Integr. Med. 2010, 7.
84. Grzanna, M.W.; Secor, E.J.; Fortuno, L.V.; Au, A.Y.; Frondoza, C.G. Anti-Inflammatory Effect of Carprofen Is Enhanced by Avocado/Soybean Unsaponifiables, Glucosamine and Chondroitin Sulfate Combination in Chondrocyte Microcarrier Spinner Culture. Cartilage 2018, 1947603518783495.
85. Tanideh, N.; Zare, Z.; Jamshidzadeh, A.; Lotfi, M.; Azarpira, N.; Sepehrimanesh, M.; Koohi-Hosseinabadi, O. Hydroethanolic extract of Psidium guajava leaf for induced osteoarthritis using a guinea pig model. Biotech. Histochem. 2017, 92, 417–424.
86. De Jong, A.; Plat, J.; Mensink, R.P. Metabolic effects of plant sterols and stanols. J. Nutr. Biochem. 2003, 14, 362–369.
87. Appelboom, T.; Schuermans, J.; Verbruggen, G.; Henrotin, Y.; Reginster, J.-Y. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. Scand. J. Rheumatol. 2001, 30, 242–247.
88. Lequesne, M.; Maheu, E.; Cadet, C.; Dreiser, R.L. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Care Res. Off. J. Am. Coll. Rheumatol. 2002, 47, 50–58.
89. Darestani, R.T.; Bakhshi, H.; Sahraee, R. Comparing the efficacy and safety of Diclofenac and Piascledine in patients with knee osteoarthritis. Pajoohandeh J. 2013, 17, 272–278.
90. Carrillo, J.L.M.; García, F.P.C.; Coronado, O.G.; García, M.A.M.; Cordero, J.F.C. Physiology and Pathology of Innate Immune Response Against Pathogens. In Physiology and Pathology of Immunology; IntechOpen: London, UK, 2017.
91. Aribi, M. Introductory Chapter: Immune system dysfunction and autoimmune diseases. Immunopathog. Immune-Based Ther. Sel. Autoimmune Disord. 2017, 1.
92. Maranduba, C.M.d.C.; De Castro, S.B.R.; Souza, G.T.d.; Rossato, C.; da Guia, F.C.; Valente, M.A.S.; Rettore, J.V.P.; Maranduba, C.P.; Souza, C.M.d.; Carmo, A.M.R.d. Intestinal microbiota as modulators of the immune system and neuroimmune system: Impact on the host health and homeostasis. J. Immunol. Res. 2015, 2015.
93. Sprague, A.H.; Khalil, R.A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 2009, 78, 539–552.
94. Jablonska, S. Avocado/soybean unsaponifiables in the treatment of scleroderma: Comment on the article by Maheu et al. Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 1998, 41, 1705.
95. Azadbakht, L.; Shakerhosseini, R.; Atabak, S.; Jamshidian, M.; Mehrabi, Y.; Esmaill-Zadeh, A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur. J. Clin. Nutr. 2003, 57, 1292.
96. Anderson, G.H.; Li, E.; Anthony, S.P.; Ng, L.T.; Bialik, R. Dissociation between plasma and brain amino acid profiles and short-term food intake in the rat. Am. J. Physiol. -Regul. Integr. Comp. Physiol. 1994, 266, R1675–R1686.
97. Zhao, J.-h.; Sun, S.-j.; Horiguchi, H.; Arao, Y.; Kanamori, N.; Kikuchi, A.; Oguma, E.; Kayama, F. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice. Int. Immunopharmacol. 2005, 5, 1601–1610.
98. Zhu, C.; Wu, Y.; Jiang, Z.; Zheng, C.; Wang, L.; Yang, X.; Ma, X.; Gao, K.; Hu, Y. Dietary soy isoflavone attenuated growth performance and intestinal barrier functions in weaned piglets challenged with lipopolysaccharide. Int. Immunopharmacol. 2015, 28, 288–294.
99. Young, D.; Ibuki, M.; Nakamori, T.; Fan, M.; Mine, Y. Soy-derived di-and tripeptides alleviate colon and ileum inflammation in pigs with dextran sodium sulfate-induced colitis. J. Nutr. 2011, 142, 363–368.
100. Santoro, N.; Epperson, C.N.; Mathews, S.B. Menopausal symptoms and their management. Endocrinol. Metab. Clin. 2015, 44, 497–515.
101. Baker, F.C.; De Zambotti, M.; Colrain, I.M.; Bei, B. Sleep problems during the menopausal transition: Prevalence, impact, and management challenges. Nat. Sci. Sleep 2018, 10, 73.
102. Kuh, D.; Muthuri, S.; Cooper, R.; Moore, A.; Mackinnon, K.; Cooper, C.; Adams, J.; Hardy, R.; Ward, K. Menopause, reproductive life, hormone replacement therapy, and bone phenotype at age 60–64 years: A British birth cohort. J. Clin. Endocrinol. Metab. 2016, 101, 3827–3837.
103. Suthar, A.; Banavalikar, M.; Biyani, M. Pharmacological activities of Genistein, an isoflavone from soy (Glycine max): Part II—Anti-cholesterol activity, effects on osteoporosis & menopausal symptoms. IJEB 2001, 39.
104. Levis, S.; Strickman-Stein, N.; Ganjei-Azar, P.; Xu, P.; Doerge, D.R.; Krischer, J. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: A randomized, double-blind trial. Arch. Intern. Med. 2011, 171, 1363–1369.
105. Panahi, Y.; Beiraghdar, F.; Kashani, N.; Javan, N.B. Comparison of piascledine (avocado and soybean oil) and hormone replacement therapy in menopausal-induced hot flashing. Iran. J. Pharm. Res. Ijpr 2011, 10, 941.
106. Nair, P.A. Dermatosis associated with menopause. J. Mid-Life Health 2014, 5, 168.
107. Akbari, T.N.; DAVOODABADI, F.M. COMPARATIVE EFFECTS OF FLAXSEED, SOY ON MENOPAUSAL HOT FLASHES. Complementary Med. J. Fac. Nurs. Midwifery Fall 2012, 2, 52–60.
108. Lewis, J.E.; Nickell, L.A.; Thompson, L.U.; Szalai, J.P.; Kiss, A.; Hilditch, J.R. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause 2006, 13, 631–642.
109. Fontvieille, A.; Dionne, I.; Riesco, E. Long-term exercise training and soy isoflavones to improve quality of life and climacteric symptoms. Climacteric 2017, 20, 233–239.
110. Monroe, K.R.; Murphy, S.P.; Henderson, B.E.; Kolonel, L.N.; Stanczyk, F.Z.; Adlercreutz, H.; Pike, M.C. Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: The Multiethnic Cohort Study. HNUC 2007, 58, 127–135.